Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (Q58617336)

ORCID Public Data File 2021

Michael A. Piradov

1 reference

ORCID Public Data File 2021

language of work or name

English

0 references

publication date

2 November 2018

0 references

published in

Lancet Neurology

0 references

volume

17

0 references

issue

12

0 references

page(s)

1083-1097

0 references

cites work

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Association of cigarette smoking with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Age-specific ALS incidence: a dose-response meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Incidence of amyotrophic lateral sclerosis in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

The PRO-ACT database: design, initial analyses, and predictive features

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Estimating distributions of health state severity for the global burden of disease study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Amyotrophic Lateral Sclerosis Mimic Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Characteristics and Prognosis of Oldest Old Subjects with Amyotrophic Lateral Sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Genetic risk assessment in carrier testing for spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Differences in SMN1 allele frequencies among ethnic groups within North America

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Prognosis of amyotrophic lateral sclerosis and the effect of referral selection.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Amyotrophic lateral sclerosis: moving towards a new classification system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Amyotrophic lateral sclerosis and motor neuron syndromes in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

ALS clinical trials: Do enrolled patients accurately represent the ALS population?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Referral bias in ALS epidemiological studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930404-6

7 January 2021

Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30409709

12 December 2020

inferred from PubMed ID database lookup

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30409709

12 December 2020